These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2177368)

  • 1. The action of gliclazide on insulin secretion and insulin sensitivity in non-obese non-insulin dependent diabetic patients.
    Chang TC; Wang LM; Cheng CY; Kuo HF; Liu PC; Ho LT
    Zhonghua Yi Xue Za Zhi (Taipei); 1990 Aug; 46(2):79-85. PubMed ID: 2177368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of insulin secretion and insulin sensitivity between normal and impaired glucose tolerance subjects with normal fasting plasma glucose.
    Tang KT; Ho LT; Jap TS; Chang TC; Ching KN; Lam HC; Wu MS; Lee SP
    Zhonghua Yi Xue Za Zhi (Taipei); 1990 Aug; 46(2):73-8. PubMed ID: 2177367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of gliclazide treatment on insulin secretion and beta-cell mass in non-insulin dependent diabetic Goto-Kakisaki rats.
    Dachicourt N; Bailbé D; Gangnerau MN; Serradas P; Ravel D; Portha B
    Eur J Pharmacol; 1998 Nov; 361(2-3):243-51. PubMed ID: 9865514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short- and long-term gliclazide effects on pancreatic islet cell function and hepatic insulin extraction in non-insulin-dependent diabetes mellitus.
    Wajchenberg BL; Santomauro AT; Giannella-Neto D; Borghi VC; Porrelli RN
    Diabetes Res Clin Pract; 1992 Aug; 17(2):89-97. PubMed ID: 1425152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gliclazide mainly affects insulin secretion in second phase of type 2 diabetes mellitus.
    Ligtenberg JJ; Reitsma WD; van Haeften TW
    Horm Metab Res; 2001 Jun; 33(6):361-4. PubMed ID: 11456286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of beta-cell function after long-term treatment with either insulin, insulin plus gliclazide or gliclazide in neonatal streptozotocin-induced non-insulin-dependent diabetic rats.
    Kawai K; Suzuki S; Murayama Y; Watanabe Y; Yamashita K
    Diabetes Res Clin Pract; 1991 Jul; 12(3):163-72. PubMed ID: 1832376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Features of insulin secretion and insulin resistance in newly diagnosed type 2 diabetes of different body mass indices].
    An YL; Gao Y; Zhu Q; Ning G; Jia WP; Huang Q; Xu W; Li CJ; Zhou ZG; Shi BY; Shan ZY; Chen LL; Xu ZR; Wang H; Yan L; Zhong HJ; Ji QH; Li H; Xue YM; Zhing MX; Gu W; Guo XH; Gao LL; Hong J; Liu F; Zou DJ; Li YB; Zhang XY; Li Z; Guo G; Zhao XJ; Wu HN; Wang YZ; Zhao WG; Zhang SL; Wu J; Zhang NY; Yang FY; Zhang Y; Zhou XR; Ren YZ; Li GW
    Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(16):1117-21. PubMed ID: 19595144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin action and insulin secretion in newly diagnosed type 2 diabetic patients.
    Tzeng TF; Chen JH; Hsiao PJ; Hsieh MC; Shin SJ
    Kaohsiung J Med Sci; 2001 Sep; 17(9):468-74. PubMed ID: 11842650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of sulphonylurea therapy on skeletal muscle glycogen synthase activity and insulin secretion in newly presenting type 2 (non-insulin-dependent) diabetic patients.
    Johnson AB; Argyraki M; Thow JC; Jones IR; Broughton D; Miller M; Taylor R
    Diabet Med; 1991 Apr; 8(3):243-53. PubMed ID: 1828740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged sulfonylurea administration decreases insulin resistance and increases insulin secretion in non-insulin-dependent diabetes mellitus: evidence for improved insulin action at a postreceptor site in hepatic as well as extrahepatic tissues.
    Mandarino LJ; Gerich JE
    Diabetes Care; 1984; 7 Suppl 1():89-99. PubMed ID: 6376034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of gliclazide on plasma insulin, intact and 32/33 split proinsulin in South Asian subjects with Type 2 diabetes mellitus.
    Ammari F; Davies MJ; Koppiker N; Gregory R; Burden AC
    Diabet Med; 1999 Feb; 16(2):142-6. PubMed ID: 10229308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus.
    Gumbiner B; Polonsky KS; Beltz WF; Griver K; Wallace P; Brechtel G; Henry RR
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1594-602. PubMed ID: 2189885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gliclazide potentiates suppression of hepatic glucose production in non-insulin-dependent diabetic patients.
    Riccio A; Lisato G; de Kreutzenberg SV; Marchetto S; Turrin M; Tiengo A; Del Prato S
    Metabolism; 1996 Oct; 45(10):1196-202. PubMed ID: 8843172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of 6-month gliclazide treatment on insulin release and sensitivity to endogenous insulin in NIDDM: role of initial continuous subcutaneous insulin infusion-induced normoglycemia.
    Della Casa L; del Rio G; Glaser B; Cerasi E
    Am J Med; 1991 Jun; 90(6A):37S-45S. PubMed ID: 1872303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute and chronic effects of dexfenfluramine on glucose and insulin response to intravenous glucose in diabetic and non-diabetic obese subjects.
    Glaser B; Raveh Y; Norynberg C; Berry E; Lavielle R; Nathan C; Cerasi E
    Diabetes Res; 1992; 19(4):165-76. PubMed ID: 1343113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: efficacy and change of insulin secretion.
    Lee WJ; Ser KH; Chong K; Lee YC; Chen SC; Tsou JJ; Chen JC; Chen CM
    Surgery; 2010 May; 147(5):664-9. PubMed ID: 20004451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
    Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S;
    J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of Diamicron on the secretion and action of insulin.
    Chiasson JL; Hamet P; Verdy M
    Diabetes Res Clin Pract; 1991; 14 Suppl 2():S47-51. PubMed ID: 1794265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients.
    Miyazaki Y; DeFronzo RA
    Diabetes Obes Metab; 2008 Dec; 10(12):1204-11. PubMed ID: 18476983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretion and hepatic extraction of insulin after weight loss in obese noninsulin-dependent diabetes mellitus.
    Henry RR; Brechtel G; Griver K
    J Clin Endocrinol Metab; 1988 May; 66(5):979-86. PubMed ID: 3283164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.